IFNG and neoplasm: Unlike static biomarkers, exo-PD-L1 integrates upstream oncogenic signals (e.g., IFN-γ/JAK-STAT), microenvironmental factors (e.g., hypoxia), and downstream immune suppression, serving as both a functional and temporal indicator of tumor immune escape (40).